The removal of pharmaceuticals from the market is a dramatic demonstration of the urgency of implementing better approaches for the early detection of drug toxicity. This paper summarizes the attempts to predict mutagenicity and carcinogenicity from the chemical structure. The limitations of the available commercial systems are pointed out and the urgency of integrating higher levels of chemical knowledge is stressed.